Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Controlled Study to Evaluate Use of CereGate Therapy to Reduce Freezing of Gait in Participants Diagnosed With Parkinson's Disease

NCT05292794 is registered in ClinicalTrials.gov with CereGate Inc. as lead sponsor.

NCT NCT05292794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05292794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Controlled Study to Evaluate Use of CereGate Therapy to Reduce Freezing of Gait in Participants Diagnosed With Parkinson's Disease
Lead sponsor
CereGate Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
April 18, 2022
Completion date
July 31, 2027
Enrollment
41 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

deep brain stimulation, freezing of gait, parkinson disease